A new twist for SSRIs - potential role as adjuncts for cancer therapy thanks to the pioneering work of Dr. Lili Yang.
A UCLA study suggests that common antidepressants could enhance the immune system’s ability to fight #cancer and suppress tumor growth. Repurposing these existing FDA-approved drugs could speed up the process of bringing new cancer treatments to patients. stemcell.ucla.edu/news/common-...
A widely used antidepressant drug could help the immune system fight cancer, according to a new UCLA research study.Selective serotonin reuptake inhibitors, or SSRIs, significantly enhanced the abilit...
